Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

IFF International Flavors & Fragrances

92.810
+1.980+2.18%
Close 10/03 16:00 ET
92.8100.0000.00%
Pre Mkt Price 10/04 07:00 ET
High
93.385
Open
92.100
Turnover
194.79M
Low
91.290
Pre Close
90.830
Volume
2.10M
Market Cap
23.66B
P/E(TTM)
36.54
52wk High
150.886
Shares
254.95M
P/E(Static)
84.37
52wk Low
89.960
Float Cap
20.81B
Bid/Ask %
-81.82%
Historical High
152.000
Shs Float
224.22M
Volume Ratio
1.14
Historical Low
9.183
Dividend TTM
3.16
Div Yield TTM
3.12
P/B
1.17
Dividend LFY
3.40%
Div Yield LFY
3.36%
Turnover Ratio
0.94%
Amplitude
2.31%
Avg Price
92.737
Lot Size
1
Float Cap
20.81B
Bid/Ask %
-81.82%
Historical High
152.000
Shs Float
224.22M
Volume Ratio
1.14
Historical Low
9.183
Dividend TTM
3.16
P/B
1.17
Dividend LFY
3.40%
Turnover Ratio
0.94%
Amplitude
2.31%
Avg Price
92.737
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world’s finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.
CEO: Mr. Franklin K. Clyburn, Jr
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...